Evidence map›Paper›PMID 26179106›Full record

ArticleChembiochem : a European journal of chemical biology2015

Ribosomal Synthesis of Natural-Product-Like Bicyclic Peptides in Escherichia coli.

Nina Bionda, Rudi Fasan

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Journal of the American Chemical Society · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Biosynthetic Strategies for Macrocyclic Peptides.Molecules (Basel, Switzerland) · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Enzyme stabilization via computationally guided protein stapling.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  18. Bicyclic Peptides as Next-Generation Therapeutics.Chemistry (Weinheim an der Bergstrasse, Germany) · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nina BiondaDepartment of Chemistry, University of Rochester, RC Box 270216, Rochester, NY, 14627, USA.
Rudi FasanDepartment of Chemistry, University of Rochester, RC Box 270216, Rochester, NY, 14627, USA. fasan@chem.rochester.edu.
University of Rochester · US

Funding

Macrocyclic inhibitors of upstream protein activators of the Hedgehog pathwayR21CA187502 · NCI · UNIVERSITY OF ROCHESTER · PI FASAN, RUDI · 2014 to 2015
$367k
NCI NIH HHS R21 CA187502
6 · The paper itself

Abstract

Methods to access natural-product-like macrocyclic peptides can disclose new opportunities for the exploration of this important structural class for chemical biology and drug discovery applications. Here, the scope and mechanism of a novel strategy for directing the biosynthesis of thioether-bridged bicyclic peptides in bacterial cells was investigated. This method entails split intein-catalyzed head-to-tail cyclization of a ribosomally produced precursor peptide, combined with inter-side-chain crosslinking through a genetically encoded cysteine-reactive amino acid. This strategy could be successfully applied to achieve formation of structurally diverse bicyclic peptides with high efficiency and selectivity in Escherichia coli. Insights into the sequence of reactions underlying the peptide bicyclization process were gained from time-course experiments. Finally, the potential utility of this methodology toward the discovery of macrocyclic peptides with enhanced functional properties was demonstrated through the isolation of a bicyclic peptide with sub-micromolar affinity for streptavidin.

Indexed as

InteinsProtein BiosynthesisAmino Acid SequenceBiological ProductsEscherichia coliGenetic EngineeringMolecular Sequence DataPeptides, CyclicSulfidesBiological ProductsPeptides, CyclicSulfidesbicyclic peptidesribosomal synthesissplit inteinsthioether bridgesunnatural amino acids

Identifiers

PMID26179106
PMCPMC4573908
OpenAlexW1726297551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.